Annual Shareholders Equity
$13.16 M
+$28.26 M+187.18%
December 31, 2023
Summary
- As of February 8, 2025, INTS annual stockholders equity is $13.16 million, with the most recent change of +$28.26 million (+187.18%) on December 31, 2023.
- During the last 3 years, INTS annual shareholders equity has risen by +$14.72 million (+944.64%).
- INTS annual shareholders equity is now at all-time high.
Performance
INTS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$2.78 M
-$2.57 M-48.01%
September 30, 2024
Summary
- As of February 8, 2025, INTS quarterly stockholders equity is $2.78 million, with the most recent change of -$2.57 million (-48.01%) on September 30, 2024.
- Over the past year, INTS quarterly shareholders equity has stayed the same.
- INTS quarterly shareholders equity is now -82.53% below its all-time high of $15.91 million, reached on September 30, 2023.
Performance
INTS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
INTS Shareholders Equity Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +187.2% | 0.0% |
3 y3 years | +944.6% | +117.4% |
5 y5 years | +654.0% | +117.4% |
INTS Shareholders Equity Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +187.2% | -82.5% | +117.4% |
5 y | 5-year | at high | +187.2% | -82.5% | +117.4% |
alltime | all time | at high | +187.2% | -82.5% | +117.4% |
Intensity Therapeutics Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $2.78 M(-48.0%) |
Jun 2024 | - | $5.34 M(-45.0%) |
Mar 2024 | - | $9.72 M(-26.1%) |
Dec 2023 | $13.16 M(-187.2%) | $13.16 M(-17.3%) |
Sep 2023 | - | $15.91 M(+5.1%) |
Jun 2023 | - | $15.13 M(-194.8%) |
Mar 2023 | - | -$15.96 M(+5.7%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2022 | -$15.10 M(+73.9%) | -$15.10 M(+21.0%) |
Jun 2022 | - | -$12.48 M(+15.8%) |
Mar 2022 | - | -$10.78 M(+24.1%) |
Dec 2021 | -$8.68 M(+457.3%) | - |
Dec 2021 | - | -$8.68 M(+32.8%) |
Sep 2021 | - | -$6.54 M(+319.6%) |
Dec 2020 | -$1.56 M(-34.4%) | -$1.56 M |
Dec 2019 | -$2.38 M | - |
FAQ
- What is Intensity Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Intensity Therapeutics?
- What is Intensity Therapeutics annual shareholders equity year-on-year change?
- What is Intensity Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Intensity Therapeutics?
- What is Intensity Therapeutics quarterly shareholders equity year-on-year change?
What is Intensity Therapeutics annual stockholders equity?
The current annual shareholders equity of INTS is $13.16 M
What is the all time high annual shareholders equity for Intensity Therapeutics?
Intensity Therapeutics all-time high annual stockholders equity is $13.16 M
What is Intensity Therapeutics annual shareholders equity year-on-year change?
Over the past year, INTS annual stockholders equity has changed by +$28.26 M (+187.18%)
What is Intensity Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of INTS is $2.78 M
What is the all time high quarterly shareholders equity for Intensity Therapeutics?
Intensity Therapeutics all-time high quarterly stockholders equity is $15.91 M
What is Intensity Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, INTS quarterly stockholders equity has changed by $0.00 (0.00%)